Cystic Fibrosis Therapeutic Pipeline Analysis Covering 75+ Companies and 80+ Pipeline Therapies

Companies across the globe are diligently working toward the development of novel therapies for the treatment of Cystic Fibrosis, with a considerable amount of success over the years. As per DelveInsight's assessment, globally, about 75+ pharma companies are working on 80+ pipeline drugs in the Cystic Fibrosis therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

The leading companies with their Cystic Fibrosis therapies in the advanced stage of clinical development include Algi Pharma, Verona Pharmaceuticals, Translate Bio, Eloxx Pharmaceuticals, Inc., Calithera Biosciences, Vertex Pharmaceuticals, Santhera Pharmaceuticals, Krystal Biotech, Laurent Pharmaceuticals Inc., SpliSense, and others. Furthermore, the promising pipeline therapies in the therapeutics domain include ELX-02 (Eloxx Pharmaceuticals, Inc.), Lonodelestat (Santhera Pharmaceuticals, Inc.), LAU-7b (Laurent Pharmaceuticals Inc.), and others.

"Cystic Fibrosis Pipeline Insight, 2022" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Cystic Fibrosis Therapeutics Market.

The report provides a detailed description of the drug, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any).

The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Cystic Fibrosis Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing therapies in the Cystic Fibrosis Market.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Cystic Fibrosis treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Cystic Fibrosis market.

The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

The Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage products (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates

Request for Sample PDF to Understand More About the Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/report-store/cystic-fibrosis-pipeline?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Cystic Fibrosis Therapeutics Analysis
Globally, there are approx. 75+ key companies which are developing therapies for Cystic Fibrosis. Algi Pharma has its Cystic Fibrosis drug candidates in the most advanced stage of clinical development.

The Leading Companies in the Cystic Fibrosis Therapeutics Market Include:
Krystal Biotech, Vertex Pharmaceuticals, Translate Bio, Novartis, Algi Pharma, Verona Pharma, Atlantic Healthcare, Calithera Biosciences, Horizon Therapeutics, Santhera Pharmaceuticals, Reveragen Biopharma, Spli Sense, GlaxosmithKline, EmphyCorp, Abbvie, Galapagos NV, Vertex Pharmaceuticals, PathBio Analytics, AstraZeneca, AxentisPharma AG, and others.

Cystic Fibrosis Emerging Therapies Covered in the Report Include:
• OligoG: Algi Pharma
• Ensifentrine: Verona Pharma
• MRT5005: Translate Bio
• CB280: Calithera Biosciences
• KB407 : Krystal Biotech
• SPL84231: SpliSense
• ELX-02: Eloxx Pharmaceuticals, Inc.
• Lonodelestat: Santhera Pharmaceuticals, Inc
• LAU-7b: Laurent Pharmaceuticals Inc.
And many others

Download Sample Pages to Get an in-depth Assessment of the Emerging Therapies and Key Companies:
https://www.delveinsight.com/sample-request/cystic-fibrosis-pipeline?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Cystic Fibrosis Current Treatment Patterns
4. Cystic Fibrosis - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Cystic Fibrosis Late Stage Products (Phase-III)
7. Cystic Fibrosis Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Cystic Fibrosis Discontinued Products
13. Cystic Fibrosis Product Profiles
14. Cystic Fibrosis Key Companies
15. Cystic Fibrosis Key Products
16. Dormant and Discontinued Products
17. Cystic Fibrosis Unmet Needs
18. Cystic Fibrosis Future Perspectives
19. Cystic Fibrosis Analyst Review
20. Appendix
21. Report Methodology
*The table of contents is not exhaustive; the final content may vary.

Request the Sample PDF to Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/cystic-fibrosis-pipeline?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Contact Info:

Anuj Rawat
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.